Journal
JOURNAL OF RHEUMATOLOGY
Volume 42, Issue 8, Pages 1448-1454Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.141443
Keywords
MYOSITIS; POLYMYOSITIS; DERMATOMYOSITIS; AUTOIMMUNITY; MUSCLE
Categories
Funding
- Intramural NIH HHS [Z99 AR999999, ZIA AR041203-01] Funding Source: Medline
- NIAMS NIH HHS [R56 AR062615, R56 AR062615-01A1, P30-AR-053503, P30 AR053503] Funding Source: Medline
Ask authors/readers for more resources
Objective. Individual dermatomyositis (DM)-associated autoantibodies are associated with distinct clinical phenotypes. This study was undertaken to explore the association of these autoantibodies with specific muscle biopsy features. Methods. DM subjects with a muscle biopsy reviewed at Johns Hopkins had sera screened for autoantibodies recognizing Mi-2, transcriptional intermediary factor 1-gamma (TIF1-gamma), NXP2, MDA5, Ro52, PM-Scl, and Jo1. We also included anti-Jo1-positive patients with polymyositis (PM) who had a biopsy read at Johns Hopkins. Analyzed histological features included perifascicular atrophy, perivascular inflammation, mitochondrial dysfunction, primary inflammation, and myofiber necrosis. Duration of disease, biopsy location, and treatment at biopsy were also analyzed. Results. We studied 91 DM and 7 anti-Jo1-positive patients with PM. In univariate analyses, TIF1-gamma+ patients had more mitochondrial dysfunction (47% vs 18%; p = 0.05), NXP2+ patients had less primary inflammation (0% vs 28%; p = 0.01), Mi-2+ patients had more primary inflammation (50% vs 19%; p = 0.03), and PM-Scl+ patients had more primary inflammation (67% vs 18%; p = 0.004) than those who were negative for each autoantibody. Although reliability was limited because of small sample numbers, multivariate analysis confirmed that TIF1-gamma+ patients had more mitochondrial dysfunction [prevalence ratio (PR) 2.6, 95% CI 1.0-6.5, p = 0.05] and PM-Scl+ patients had more primary inflammation (PR 5.2, 95% CI 2.0-13.4; p = 0.001) independent of disease duration at biopsy, biopsy site, and treatment at biopsy. No differences in muscle biopsy features were noted between anti-Jo1-positive patients diagnosed with DM and PM. Conclusion. The prevalence of different histological features varies according to autoantibody status in DM. Muscle biopsy features are similar in anti-Jo1 patients with and without a rash.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available